Mesa Laboratories, Inc.: Expect to Record Non-Cash Impairment Losses Related to Clinical Genomics and Biopharmaceutical Development Divisions of About $271M During 4Q FY24 >MLAB
Mesa Laboratories, Inc.: Expect to Record Non-Cash Impairment Losses Related to Clinical Genomics and Biopharmaceutical Development Divisions of About $271M During 4Q FY24 >MLAB
Mesa Laboratories, Inc.：預計將在24財年第四季度記錄與臨床基因組學和生物製藥開發部門相關的非現金減值損失約2.71億美元 >MLAB
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊